Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Dallas-Fort Worth-Arlington, TX Metro Edition
Focus: LIFE SCI
4.4%
DFW unemployment rate
Up from 4.1% in February 2026
$1,785
DFW average weekly wage
vs $1,654 U.S. average, Q1 2026
129,245 workers
Texas life sciences employment
21.6% growth since 2019, 9,212 establishments
$8.8B combined
New Houston biomanufacturing investment
Lilly ($6.5B) + BMS ($2.3B), Generation Park
This Month's Takeaways
Metro median advertised pay for Regulatory Affairs Specialists sits at $107,217, up significantly, versus a flat national figure near $104,000. Local scarcity appears to be driving compensation above typical geographic discount expectations for Dallas, a signal worth testing against current offer structures.
Metro median rose significantly to $122,953 while the national median declined moderately to $123,031 — a reversal that may suggest DFW employers are competing harder for data management talent even as national demand softens. Treat this as a local anomaly worth monitoring rather than assuming convergence with national trend lines.
Metro median for Clinical Research Associates moved up moderately to $65,000, but still trails the national median of $90,956 by a significant margin. Clinical ops roles may remain a stronger candidate for CRO partnership than in-house hiring in this market, particularly given state-level skew toward regional operations rather than headquarters functions.
Eli Lilly's and Bristol Myers Squibb's combined $8.8B in new Houston-area manufacturing capacity creates statewide competition for quality and process talent, not just a regional one. Validation Engineer pay in DFW is already up significantly to $96,858, consistent with early spillover pressure on quality-adjacent roles.
Local Labor Conditions
DFW unemployment climbed to 4.4% in August against a backdrop of 54,000 jobs added over the year, but Information sector losses of 2.8% signal selective softening even as Professional and Business Services and Education/Health Services sectors continue expanding. Eli Lilly's $6.5B Houston facility and Bristol Myers Squibb's $2.3B Generation Park investment are pulling biomanufacturing talent statewide, tightening the specific credential pools DFW life sciences employers compete for even as headline unemployment rises.
Leadership & Talent Implications
Metro-wide labor softening does not extend to life sciences specialty talent — advertised pay for Regulatory Affairs Specialists ($107,217 metro median, up significantly) and Research Scientists ($123,070, up significantly) is accelerating even as broader DFW wage growth trails the national rate. Statewide manufacturing capacity expansion in Houston reduces the case for assuming CDMO outsourcing is reliably cheaper than regional insourcing, since the same skilled operator and quality-specialist pools are now contested across Texas metros. Consider reviewing build-vs-outsource manufacturing assumptions against current in-state capacity competition rather than historical cost comparisons.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | $78,366 | $123,070 | $125,334 | ↑ Significant increase | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $57,102 | $65,000 | $70,113 | ↑ Moderate increase | $90,956 | ↑ Significant increase |
| Lab Technician | $38,796 | $47,840 | $51,604 | → Stable | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | $73,465 | $107,217 | $116,091 | ↑ Significant increase | $104,000 | → Stable |
| Clinical Data Manager | $100,190 | $122,953 | $122,953 | ↑ Significant increase | $123,031 | ↓ Moderate decline |
| Biostatistician | $82,886 | $83,465 | $90,989 | ↑ Significant increase | $133,322 | ↑ Moderate increase |
| Validation Engineer | $73,478 | $96,858 | $105,780 | ↑ Significant increase | $108,377 | ↑ Moderate increase |
Looking Ahead · Next 30–60 Days
Worth watching
DFW unemployment has risen from 4.1% in February to 4.4% in August — watch whether this normalization reaches specialized scientific and regulatory roles or stays concentrated in Information and general metro employment.
Emerging pressure point
San Jacinto College's NIBRT-licensed biotechnology training center opened in the region as the only one of its kind in the southern U.S. Watch whether graduate output begins easing Lab Technician and entry-level manufacturing talent constraints over the next two cohorts.
Potential inflection point
Houston's $8.8B in new biomanufacturing capacity (Lilly, BMS) may begin drawing experienced quality and process talent away from DFW employers as hiring ramps. Monitor whether Validation Engineer and CMC-adjacent postings show accelerating wage pressure as a leading indicator.
Early indicator
National biopharma WARN activity concentrated in consolidation-driven roles (BioMarin, Bristol Myers) rather than execution functions. Track whether any displaced regulatory or clinical talent surfaces in the DFW candidate pool, which could temporarily ease the current scarcity in those specific functions.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.